Missed the live event? Watch the full recording here!
More than 70,000 patients worldwide live with CF, and for one in ten CF patients, there are currently no effective, disease-modifying treatments available. At Translate Bio, we are making progress in the development of an mRNA therapy for this disease, which has the potential to treat all CF patients regardless of their genetic mutation.
“Translating Now,” an event held at Translate Bio in May 2019, highlighted research progress for CF treatments while reminding the community that the fight to develop new medicines is far from finished. The panel discussion was moderated by Meagan Vaughn, senior clinical research scientist at Rho, and featured several different voices within the CF community, including:
- Emily Kramer-Golinkoff, co-founder of Emily’s Entourage living with advanced stage CF
- Bob Coughlin, President and CEO of MassBio and a parent of a child with CF
- Dr. Jonathan Zuckerman, MD, Director of Maine Medical Center’s Adult Cystic Fibrosis Clinic
- Dr. Ann Barbier, Translate Bio’s Chief Medical Officer
Questions? Contact Maura Gavaghan at email@example.com.